Skip to Content
Søk Menu
Onkologi
Velkommen til onkologi

Her får du det ny klinisk kunnskap og best practice innen ditt spesialfelt

ASCO 2026

Jana De Boniface

ASCO 2026: SENOMAC Supports Omission of Completion Axillary Dissection

/ Jana de Boniface
ASCO26Brystkreft Play the Video
Pedro Barata

ASCO 2026: Phase III Study Evaluates Novel Radiopharmaceutical in mCRPC

/ Pedro Barata
ASCO26Prostatakreft Play the Video
Gini Fleming

ASCO 2026: Telisotuzumab Adizutecan Shows Promising Activity in Platinum-Resistant Ovarian Cancer

/ Gini Fleming
ASCO26Ovariecancer Play the Video
Mattia D' Agostino

ASCO 2026: Sustained MRD and Outcomes in Multiple Myeloma

/ Mattia D' Agostino
ASCO26Myelomatose Play the Video
Martin Birkmose Rasmussen

Biomarkers May Improve Treatment Selection and Respons in BTC

/ Martin Birkmose Rasmussen
ASCO26 Play the Video
Load more

Nytt fra onkologi

Ada Junquera

Spatial Sub-Sister Cell Trajectories in High-Grade Serous Ovarian Cancer

/ Ada Junquera
Ovariecancer Play the Video
Ricardo Coelho

Tumor-Associated Macrophages and TNF-α May Help Rescue Treatment Efficacy in Ovarian Cancer

/ Ricardo Coelho
Ovariecancer Play the Video
Riccardo Soffietti

EAN 2026: How IDH Inhibitors Are Transforming Low-Grade Glioma Treatment

/ Riccardo Soffietti
EAN26 Play the Video
Giampaolo Bianchini

ESMO Breast 2026: Optimizing Immunotherapy in Early TNBC

/ Giampaolo Bianchini
Brystkreft Play the Video
Shailender Bhatia

ASCO 2026: ADAM trial Shows Improved Relapse-Free Outcomes with Adjuvant Avelumab in Stage III Merkel Cell Carcinoma

/ Shailender Bhatia
ASCO26 Play the Video
Prof. Dr. Katharina C. Kähler

ASCO 2026: Updated Phase III Data Support Daromun in Resectable Melanoma

/ Katharina C. Kähler
ASCO26Melanom Play the Video
Load more

WCLC 2026 Highlights Nordic Webinar

  • / BestPractice Nordic

International Breast Cancer Round Table: Bringing Global Insights to Nordic Practice

(Deadline: )

Onkologi • Nr. 15 • 2026

  • New Immunotherapies and Understanding of Immune-Stimulating Factors
  • First-Line Lorlatinib in ALK-Positive NSCLC
  • Blast Cells in Peripheral Blood and Cancer
Få tilgang

Onkologisk Forum

  • Meet the Experts
  • 2025
Få tilgang

Lungekreftside

Besøk vår lungekreftside
og hold deg oppdatert på den nyeste forskningen

Besøk side
Shimrit Mayer

Mapping the Spatial Landscape of Ovarian Cancer

/ Shimrit Mayer
Ovariecancer Play the Video

Følg med på nyheter fra kongresser

Back to top